Nothing Special   »   [go: up one dir, main page]

BRPI0922708A2 - peptídeos mini-hepcidina e métodos de uso do mesmo - Google Patents

peptídeos mini-hepcidina e métodos de uso do mesmo

Info

Publication number
BRPI0922708A2
BRPI0922708A2 BRPI0922708A BRPI0922708A BRPI0922708A2 BR PI0922708 A2 BRPI0922708 A2 BR PI0922708A2 BR PI0922708 A BRPI0922708 A BR PI0922708A BR PI0922708 A BRPI0922708 A BR PI0922708A BR PI0922708 A2 BRPI0922708 A2 BR PI0922708A2
Authority
BR
Brazil
Prior art keywords
minihepidine
peptides
methods
minihepidine peptides
Prior art date
Application number
BRPI0922708A
Other languages
English (en)
Inventor
Nemeth Elizabeta
Preza Gloria
Ruchala Piotr
Ganz Tomas
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of BRPI0922708A2 publication Critical patent/BRPI0922708A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
BRPI0922708A 2008-12-05 2009-12-04 peptídeos mini-hepcidina e métodos de uso do mesmo BRPI0922708A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12027708P 2008-12-05 2008-12-05
PCT/US2009/066711 WO2010065815A2 (en) 2008-12-05 2009-12-04 Mini-hepcidin peptides and methods of using thereof

Publications (1)

Publication Number Publication Date
BRPI0922708A2 true BRPI0922708A2 (pt) 2018-11-06

Family

ID=42233878

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0922708A BRPI0922708A2 (pt) 2008-12-05 2009-12-04 peptídeos mini-hepcidina e métodos de uso do mesmo

Country Status (6)

Country Link
US (2) US8435941B2 (pt)
EP (2) EP2373679B1 (pt)
CN (1) CN102245626A (pt)
AU (1) AU2009322260B2 (pt)
BR (1) BRPI0922708A2 (pt)
WO (1) WO2010065815A2 (pt)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1392345B2 (en) 2001-05-25 2018-02-28 Institut National De La Sante Et De La Recherche Medicale (Inserm) Use of hepcidin for preparing a medicament for treating disorders of iron homeostasis
EP2373679B1 (en) * 2008-12-05 2017-03-08 The Regents of The University of California Mini-hepcidin peptides and methods of using thereof
WO2013086143A1 (en) * 2011-12-09 2013-06-13 The Regents Of The University Of California Modified mini-hepcidin peptides and methods of using thereof
CN101955525B (zh) * 2010-07-13 2012-11-07 中国农业科学院兰州畜牧与兽药研究所 一种人工抗菌肽及其基因与制备方法
US9551720B2 (en) * 2011-01-26 2017-01-24 University of Pittsburgh—Of the Commonwaelth System of Higher Education Urine biomarkers for prediction of recovery after acute kidney injury: proteomics
KR102186218B1 (ko) * 2012-11-01 2020-12-03 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 에리트로페론 및 erfe 폴리펩티드 및 철 대사의 조절 방법
GB201302837D0 (en) * 2013-02-19 2013-04-03 Univ Singapore Therapeutic Agents
SG11201507226YA (en) 2013-03-15 2015-10-29 Protagonist Therapeutics Inc Hepcidin analogues and uses therof
BR112015022123B1 (pt) 2013-03-15 2022-08-09 Intrinsic Lifesciences, Llc Anticorpos, fragmentos de ligação ao antígeno dos mesmos que se ligam especificamente à hepcidina ou um peptídeo de hepcidina, uso, meio contentor e kit
WO2014147246A1 (en) 2013-03-21 2014-09-25 INSERM (Institut National de la Santé et de la Recherche Médicale) Method and pharmaceutical composition for use in the treatment of chronic liver diseases associated with a low hepcidin expression
KR20170002414A (ko) * 2014-04-07 2017-01-06 멀겐져 바이오텍, 아이엔씨. 헵시딘 모방 펩티드 및 그 용도
HRP20211448T1 (hr) 2014-05-16 2021-12-24 Protagonist Therapeutics, Inc. Alfa4beta7 integrin tioeter peptidni antagonisti
EP3161164A4 (en) * 2014-06-27 2018-04-25 Protagonist Therapeutics Inc. Hepcidin and mini-hepcidin analogues and uses therof
ES2977537T3 (es) 2014-07-17 2024-08-26 Protagonist Therapeutics Inc Inhibidores peptídicos orales del receptor de interleucina-23 y su uso para tratar enfermedades inflamatorias intestinales
CA2961917A1 (en) 2014-09-22 2016-03-31 Intrinsic Lifesciences Llc Humanized anti-hepcidin antibodies and uses thereof
US10301371B2 (en) 2014-10-01 2019-05-28 Protagonist Therapeutics, Inc. Cyclic monomer and dimer peptides having integrin antagonist activity
KR20170108936A (ko) 2014-10-01 2017-09-27 프로타고니스트 테라퓨틱스, 인코포레이티드 신규한 α4β7 펩타이드 단량체 및 이량체 길항제
WO2016109363A1 (en) 2014-12-29 2016-07-07 The Regents Of The University Of California S-Alkylated Hepcidin Peptides and Methods of Making and Using Thereof
US10787490B2 (en) 2015-07-15 2020-09-29 Protaganist Therapeutics, Inc. Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
CA3009834A1 (en) 2015-12-30 2017-07-06 Protagonist Therapeutics, Inc. Analogues of hepcidin mimetics with improved in vivo half lives
WO2017120419A1 (en) * 2016-01-08 2017-07-13 La Jolla Pharmaceutial Company Methods of administering hepcidin
WO2017165676A1 (en) 2016-03-23 2017-09-28 Protagonist Therapeutics, Inc. METHODS FOR SYNTHESIZING α4β7 PEPTIDE ANTAGONISTS
EP3497127A1 (en) * 2016-08-05 2019-06-19 Silarus Therapeutics, Inc. Erfe specific antibodies compositions and methods of use
AU2017324446A1 (en) * 2016-09-06 2019-03-28 La Jolla Pharmceutical Company Methods of treating iron overload
WO2018107241A1 (en) * 2016-12-16 2018-06-21 The University Of Sydney Treatment of iron disorders
WO2018128828A1 (en) 2016-12-23 2018-07-12 Bayer Healthcare Llc Novel hepcidin mimetics and uses thereof
WO2018175633A1 (en) * 2017-03-22 2018-09-27 La Jolla Pharmaceutical Company Methods of inducing anti-malarial immune responses and compositions related thereto
EP3681900A4 (en) 2017-09-11 2021-09-08 Protagonist Therapeutics, Inc. OPIOID AGONIST PEPTIDES AND THEIR USES
US11753443B2 (en) 2018-02-08 2023-09-12 Protagonist Therapeutics, Inc. Conjugated hepcidin mimetics
EP3894416B1 (en) 2018-12-13 2022-11-09 Global Blood Therapeutics, Inc. Ferroportin inhibitors and methods of use
AU2020311395A1 (en) 2019-07-10 2022-02-03 Protagonist Therapeutics, Inc. Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
CA3168135A1 (en) 2020-01-15 2021-07-22 Janssen Biotech, Inc. Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
CN118005736A (zh) 2020-01-15 2024-05-10 詹森生物科技公司 介白素-23受体的肽抑制剂及其治疗炎性疾病的用途
MX2022013518A (es) 2020-04-28 2023-02-01 Global Blood Therapeutics Inc Pirimidinas cicloalquiladas como inhibidores de la ferroportina.
CA3181577A1 (en) 2020-04-28 2021-11-04 Global Blood Therapeutics, Inc. Thieno pyrimidines as ferroportin inhibitors
EP4142732A1 (en) 2020-04-28 2023-03-08 Global Blood Therapeutics, Inc. Methods of use for pyrimidines as ferroportin inhibitors
CN115997130A (zh) * 2020-07-02 2023-04-21 坦佩雷大学注册基金会 基于肾素的铁调素分析
IL302996A (en) 2020-11-20 2023-07-01 Janssen Pharmaceutica Nv Compositions of peptide inhibitors of the interleukin-23 receptor
JPWO2022154121A1 (pt) * 2021-01-18 2022-07-21

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993025577A2 (en) * 1992-06-12 1993-12-23 Zenyaku Kogyo Co., Ltd. Active component of parathyroid hypertensive factor
JP2891023B2 (ja) * 1993-03-09 1999-05-17 味の素株式会社 ランチオニン含有物の製造方法
DE10228103A1 (de) 2002-06-24 2004-01-15 Bayer Cropscience Ag Fungizide Wirkstoffkombinationen
JP4638350B2 (ja) 2002-11-19 2011-02-23 ディーアールジー・インターナショナル，インコーポレイテッド ヒトまたは動物の組織、血液もしくは体液中のヘプシジンの存在または量を検出する方法
US20070166711A1 (en) 2003-04-15 2007-07-19 Samuels Mark E Juvenile hemochromatosis gene (hfe2a), expression products and uses thereof
CA2549477A1 (en) 2005-06-29 2006-12-29 The Regents Of The University Of California Competitive regulation of hepcidin mrna by soluble and cell-associated hemojuvelin
TW200900420A (en) * 2007-02-02 2009-01-01 Amgen Inc Hepcidin, hepcidin antagonists and methods of use
WO2013086143A1 (en) * 2011-12-09 2013-06-13 The Regents Of The University Of California Modified mini-hepcidin peptides and methods of using thereof
EP2373679B1 (en) * 2008-12-05 2017-03-08 The Regents of The University of California Mini-hepcidin peptides and methods of using thereof

Also Published As

Publication number Publication date
EP2373679B1 (en) 2017-03-08
WO2010065815A3 (en) 2010-10-21
AU2009322260A1 (en) 2011-07-07
EP3208279A1 (en) 2017-08-23
AU2009322260B2 (en) 2013-09-12
WO2010065815A2 (en) 2010-06-10
CN102245626A (zh) 2011-11-16
US20120040894A1 (en) 2012-02-16
EP3208279B1 (en) 2021-04-21
US20130203662A1 (en) 2013-08-08
US8435941B2 (en) 2013-05-07
EP2373679A4 (en) 2012-05-30
EP2373679A2 (en) 2011-10-12

Similar Documents

Publication Publication Date Title
BRPI0922708A2 (pt) peptídeos mini-hepcidina e métodos de uso do mesmo
BRPI1007175A2 (pt) Polipeptídeos hidroxifenilpriruvato dioxigenase mutantes e métodos de uso
BRPI0909954A2 (pt) "diazacarbazóis e métodos de uso"
BRPI1012533A2 (pt) composto de piradazinona e uso do mesmo
BRPI0916769A2 (pt) derivados de benzilbenzeno deuterados e métodos de uso
BR112012018329A2 (pt) agentes de coloração e métodos de uso destes
DOP2010000260A (es) Derivado heterociclico fusionado y su uso
BRPI0906478A2 (pt) anticorpo anti-nr10 e uso do mesmo
BRPI0821110A2 (pt) Anticorpo anti nr-10 e uso do mesmo
BRPI1014544A2 (pt) anticorpors anti-il-17f e metodos de uso dos mesmos
BRPI0915717A2 (pt) ferramenta de avaliação de cascalho e métodos de uso
BRPI0906435A2 (pt) anticorpos anti-cd79b e imunoconjugados e métodos de uso
BR112012004731A2 (pt) peptídeos derivados de wnt10 e uso dos mesmos
BRPI1012333A2 (pt) atropisômeros de derivados de 2-purinil-3-tolil-quinazolinonas e métodos de uso
BRPI1011384A2 (pt) pro-proteinas e seus metodos de uso
BR112013014321A2 (pt) moduladores inovadores e métodos de uso
BRPI0813627A2 (pt) Peptídio antimicrobiano, composições e métodos de uso
BRPI0916735A2 (pt) moduladores de tgr5 e métodos de uso do mesmo
BRPI1012676A2 (pt) anticorpos anti-fcrh5 e imunoconjugados e métodos de uso
BRPI1012560A2 (pt) anticorpos anti-fcrh5 e imunoconjugados e métodos de uso
BRPI0915928A2 (pt) composições e métodos de uso para anticorpos terapêuticos
BRPI0813514A2 (pt) anticorpos anti-cd79b humanizados e imunoconjugados e métodos de uso
BRPI0817879A2 (pt) Composições e métodos de uso de anticorpos contra esclerostina
BRPI0921992A2 (pt) moduladores tgr5 e métodos de uso destes
BRPI1007494A2 (pt) composto e uso do mesmo

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A, 7A, 8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2497 DE 13-11-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.